DWJ1622

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

TicsFasting Conditions

108 competitors in Tics

#DrugCompanyPhaseTrials

1

Sodium Valproate

AstraZeneca

Phase 3

12

Priftin

Sanofi

Phase 2

13

Nydrazid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 2

44

Duvyzat

Italfarmaco

Phase 2

25

Dilaudid

RRhodes Pharmaceuticals, L.P.

Phase 2

16

Aciphex

Akero Therapeutics

Phase 1

97

Invokana

WWim Janssens

Phase 1

88

Sprycel

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 1

39

Tylenol

KKenvue Brands

Phase 1

210

Rifampicin

Boehringer Ingelheim

Phase 1

16Show 33 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Tics1 trial

Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.

Recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT07267221·36 enrolled

Fasting Conditions1 trial

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions

Recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT07260851·40 enrolled

Details

Drug Info

Related News